BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 10584541)

  • 1. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
    Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
    Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
    Wirth S; Lang T; Gehring S; Gerner P
    Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
    Husa P; Smejkal P; Husová L; Chalupa P; Penka M
    Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Lin ZY; Hou NJ; Hsieh MY; Wang LY; Yu ML
    Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection.
    Himelhoch S
    N Engl J Med; 2001 Nov; 345(19):1426-7; author reply 1427-8. PubMed ID: 11794184
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concomitant nodular goiter during IFN and ribavirin treatment of HCV: a case report].
    Lin F; Wang HF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):163, 166. PubMed ID: 16700133
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of growth factors with antiviral therapy for chronic hepatitis C.
    Curry MP; Afdhal NH
    Clin Liver Dis; 2005 Aug; 9(3):439-51, vii. PubMed ID: 16023976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can science meet the challenges of the HCV pandemic: new treatment options for chronic hepatitis C.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Jul; 4(7):24-9. PubMed ID: 11365638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C. Saving the liver].
    Paul A
    MMW Fortschr Med; 1999 Nov; 141(46):16. PubMed ID: 10795138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hepatitis C in children].
    Ciocca M; Cuarterolo M; Ramonet M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S34-5. PubMed ID: 20214295
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An update on the treatment of chronic hepatitis C].
    Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):13-5. PubMed ID: 10756878
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C.
    Trepo C; Bailly F
    Dig Liver Dis; 2010 Apr; 42(4):283-4. PubMed ID: 20189473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.